首页> 美国卫生研究院文献>other >Cost-Effectiveness of Radiofrequency Catheter Ablation Compared with Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation

【2h】

Cost-Effectiveness of Radiofrequency Catheter Ablation Compared with Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation

机译：与阵发性心房颤动的抗真菌药物治疗相比射频导管消融的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundRadiofrequency catheter ablation (RFA) has emerged as an important treatment strategy for AF. The potential cost-effectiveness of RFA for AF, relative to antiarrhythmic drug (AAD) therapy, has not been fully explored from a U.S. perspective.

著录项

期刊名称 other
作者
Matthew R. Reynolds; Peter Zimetbaum; Mark E. Josephson; Ethan Ellis; Tatyana Danilov; David J. Cohen;
展开▼
作者单位

展开▼
年(卷),期 -1(2),4
年度 -1
页码 362–369
总页数 16
原文格式 PDF
正文语种
中图分类
关键词
atrial fibrillation ablation antiarrhythmia agents cost-benefit analysis;

机译：心房颤动;消融;抗心律不齐药物;成本效益分析;
入库时间 2022-08-21 11:30:26

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. [J] . Reynolds MR, Zimetbaum P, Josephson ME, Circulation. Arrhythmia and electrophysiology . 2009,第4期

机译：射频消融术与抗心律失常药物治疗阵发性房颤的成本效益比较。
2. A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation [J] . Du Xin, He Xiaonan, Jia Yu, Nature reviews Cancer . 2019,第6期

机译：一种长期成本效益分析，将射频导管消融与抗心律失常药物治疗中国心房颤动患者的治疗
3. A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation [J] . Du Xin, He Xiaonan, Jia Yu, American journal of cardiovascular drugs: drugs, devices, and other interventions . 2019,第6期

机译：一种长期成本效益分析，将射频导管消融与抗心律失常药物治疗中国心房颤动治疗
4. LONG-TERM EFFICACY OF ANTIARRHYTHMIC DRUG THERAPY AND ITS INFLUENCE TO THE PROGNOSIS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION [C] . KEN OKUMUR International Congress on Electrocardiology . 2005

机译：抗心律失常药物治疗的长期疗效及其对阵发性心房颤动患者预后的影响
5. Cardiac ablation as the initial therapy for symptomatic atrial fibrillation results in less recurrance of atrial fibrillation when compared to antiarrhythmic therapy [D] . Mikhli, Erica 2011

机译：与抗心律失常治疗相比，心脏消融作为症状性心房颤动的初始治疗导致心房颤动的较少复发
6. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry [O] . Lucas Boersma, Edward Koźluk, Giampiero Maglia, -1

机译：肺静脉消融导管用于阵发性和持续性房颤消融的结果
7. Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation A Randomized Controlled Trial [O] . Wilber, David J., Pappone, Carlo, Neuzil, Petr, 2010

机译：阵发性心房颤动患者抗心律失常药物治疗和射频导管消融的比较一项随机对照试验

Cost-Effectiveness of Radiofrequency Catheter Ablation Compared with Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation

摘要

著录项

相似文献

相关主题

期刊订阅